FMX
Fomento Económico Mexicano, S.A.B. de C.V.
Price as of Jul 20, 2026
FMX earnings
Fomento Económico Mexicano, S.A.B. de C.V. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Apr 30, 2026 | $0.65 | $0.92 | +41.5% | $11.7B | +2.5% |
| Feb 25, 2026 | $1.50 | $1.38 | -8.0% | $12.2B | +3.1% |
| Mar 21, 2025 | — | $1.44 | — | $10.0B | — |
| Jul 24, 2024 | $0.07 | $1.87 | +2474.3% | $10.9B | -0.9% |
| Apr 26, 2024 | $0.06 | $0.47 | +708.4% | $10.6B | -3.2% |
| Mar 22, 2024 | $1.61 | $0.09 | -94.4% | $10.6B | — |
| Oct 27, 2023 | $1.16 | $1.75 | +50.9% | $10.7B | -2.8% |
| Jul 27, 2023 | $1.21 | $1.64 | +35.5% | $11.6B | +0.7% |
| Apr 28, 2023 | $0.76 | $1.16 | +52.6% | $9.9B | +5.2% |
| Feb 24, 2023 | $1.28 | $0.69 | -46.1% | $9.5B | +10.2% |
| Oct 28, 2022 | $1.25 | $1.49 | +19.2% | $8.5B | +6.3% |
| Jul 28, 2022 | $1.04 | $1.10 | +5.8% | $8.3B | +8.1% |
Earnings call summary
Q1 FY2026 · April 30, 2026
AI summary of management’s prepared remarks and analyst Q&A. For informational purposes only — not investment advice.
Management highlights
- Changed reporting segments: OXO Medico on its own, new segment Americas and Mobility. - OXO Mexico had strong performance with revenue growth, gross margin expansion, etc. - Americas and Mobility segment had strong revenue growth. - Europe, health, and Coca-Cola Pensa had respective performances. - Organizational changes completed with renewed senior leadership teams. - SPIN had good quarter with 11 million active users and over 100 million monthly transactions.
Guidance
- Expect CapEx deployment to accelerate through the rest of the year. - Anticipate shareholder returns with ordinary and extraordinary dividends, and share repurchase program. - Optimistic but cautious about the macro environment, especially the second half of the year.
Segment performance
OXO Mexico: 8.3% revenue growth, driven by same-store sales beating industry, with growth in tobacco and soft drink categories. Gross margin expanded. Selling expense contained. Americas and Mobility: Total revenues 25 billion pesos, up 12.9%, with strong performance across OXXO Latinx and consolidation of OXXO Brazil. Europe: Total revenues 12.9 billion pesos, stable in peso terms. Health: Total revenues 22.2 billion pesos, grew 0.9% year-over-year. Coca-Cola Pensa: Remains as before with focused strategies.
Risks & headwinds
- Credit risk in Colombian healthcare institutional business due to funding gaps and potential insolvency of certain MPSs. - Challenges in traffic improvement in OXO Mexico despite progress. - Macro environment uncertainties affecting performance.
Analyst Q&A
Q: On EBITDA difference relative to last year,
A: Decline in spin losses and cost-containment efforts.
Q: Impact of Pacific area issues on traffic,
A: Traffic better than average but still not fully satisfied.
Q: Oxford gross margin and World Cup contribution,
A: No major contribution yet, but expecting more in second quarter.
Q: Affordability strategy beyond World Cup,
A: Focus on food and coffee, daily replenishment.
Q: Portfolio simplification and pharma business,
A: Always studying portfolio, pharma has potential but Mexico underperforms.
Q: New store productivity,
A: Niche stores impact, pruning underperforming stores.
Q: Ticket growth in OXO Mexico,
A: Big portion related to tax pass-through.
Q: Leverage and capital allocation,
A: Likely below target two times net debt to EBITDA by end of year.
Q: Bar expansion in north,
A: Encouraging performance, accelerating store expansion.
Q: Merchandise margins in Americas,
A: Comparable excludes Brazil, Colombia maturing well.
Q: OXO Mexico margin expansion drivers,
A: Mix of commercial income, etc.
Q: SPIN performance and tender,
A: Encouraging results, aiming for higher tender participation
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-07-28.